TSX-V:ACOG - TSX Venture Exchange - CA02074J2048 - Common Stock - Currency: CAD
Overall ACOG gets a fundamental rating of 1 out of 10. We evaluated ACOG against 24 industry peers in the Biotechnology industry. Both the profitability and financial health of ACOG have multiple concerns. ACOG does not seem to be growing, but still is valued expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -239.04% | ||
ROE | -839.02% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.89 | ||
Debt/FCF | N/A | ||
Altman-Z | -17.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.04 | ||
Quick Ratio | 2.04 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
TSX-V:ACOG (10/6/2023, 7:00:00 PM)
0.39
-0.06 (-14.29%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | N/A | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 18.79 | ||
P/tB | 34.18 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -239.04% | ||
ROE | -839.02% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.89 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 2.04 | ||
Quick Ratio | 2.04 | ||
Altman-Z | -17.23 |